DE19505263A1 - Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten - Google Patents
Verfahren zur Reinigung von wasserlöslichen CyclodextrinderivatenInfo
- Publication number
- DE19505263A1 DE19505263A1 DE19505263A DE19505263A DE19505263A1 DE 19505263 A1 DE19505263 A1 DE 19505263A1 DE 19505263 A DE19505263 A DE 19505263A DE 19505263 A DE19505263 A DE 19505263A DE 19505263 A1 DE19505263 A1 DE 19505263A1
- Authority
- DE
- Germany
- Prior art keywords
- cyclodextrin
- reverse osmosis
- water
- solution
- purification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 35
- 238000000746 purification Methods 0.000 title claims description 17
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title claims description 13
- 238000001223 reverse osmosis Methods 0.000 claims description 39
- 239000012528 membrane Substances 0.000 claims description 38
- 229920000858 Cyclodextrin Polymers 0.000 claims description 23
- 238000000926 separation method Methods 0.000 claims description 11
- 238000009792 diffusion process Methods 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 29
- 239000000243 solution Substances 0.000 description 28
- 235000002639 sodium chloride Nutrition 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000008186 active pharmaceutical agent Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 17
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 16
- 239000011780 sodium chloride Substances 0.000 description 15
- 230000033228 biological regulation Effects 0.000 description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 13
- 238000000108 ultra-filtration Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 238000009295 crossflow filtration Methods 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 239000012466 permeate Substances 0.000 description 11
- 239000012465 retentate Substances 0.000 description 11
- 239000001116 FEMA 4028 Substances 0.000 description 10
- 229960004853 betadex Drugs 0.000 description 10
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 238000004448 titration Methods 0.000 description 9
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- CUJVBAPGYBSBHJ-YWBSARSQSA-N 2-[[(1R,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21R,23R,25R,26R,28R,30R,31R,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-36,38,40,42-tetrakis(carboxymethoxy)-10,15-bis(carboxymethoxymethyl)-37,39,41,43,44,45,46,47,48,49-decahydroxy-20,25,30,35-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methoxy]acetic acid Chemical compound OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCC(O)=O)O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCC(O)=O)O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCC(O)=O)O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]1[C@H](OCC(O)=O)[C@H]2O)[C@H](O)[C@H]5OCC(O)=O)[C@H](O)[C@H]4OCC(O)=O)[C@H](O)[C@H]3OCC(O)=O CUJVBAPGYBSBHJ-YWBSARSQSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- -1 β-CD Ion Chemical class 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NZAQRZWBQUIBSF-UHFFFAOYSA-N 4-(4-sulfobutoxy)butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCOCCCCS(O)(=O)=O NZAQRZWBQUIBSF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102220605057 Histone H4-like protein type G_R75A_mutation Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical class CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19505263A DE19505263A1 (de) | 1995-02-16 | 1995-02-16 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
| US08/454,940 US5831081A (en) | 1995-02-16 | 1995-05-31 | Process for the purification of water-soluble cyclodextrin derivatives |
| JP8026674A JP2886127B2 (ja) | 1995-02-16 | 1996-02-14 | 水溶性シクロデキストリン誘導体の浄化方法 |
| DE59605527T DE59605527D1 (de) | 1995-02-16 | 1996-02-15 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
| EP96102245A EP0727440B2 (de) | 1995-02-16 | 1996-02-15 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19505263A DE19505263A1 (de) | 1995-02-16 | 1995-02-16 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE19505263A1 true DE19505263A1 (de) | 1996-08-22 |
Family
ID=7754169
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19505263A Ceased DE19505263A1 (de) | 1995-02-16 | 1995-02-16 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
| DE59605527T Expired - Lifetime DE59605527D1 (de) | 1995-02-16 | 1996-02-15 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE59605527T Expired - Lifetime DE59605527D1 (de) | 1995-02-16 | 1996-02-15 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5831081A (OSRAM) |
| EP (1) | EP0727440B2 (OSRAM) |
| JP (1) | JP2886127B2 (OSRAM) |
| DE (2) | DE19505263A1 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19605683A1 (de) * | 1996-02-16 | 1997-09-11 | Forschungszentrum Juelich Gmbh | Verfahren zur Trennung von Substanzen mittels einer geeigneten Membran |
| WO2001036490A2 (en) * | 1999-11-12 | 2001-05-25 | Pitha & Pitha Llc | Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds |
| US6527887B1 (en) | 2002-01-18 | 2003-03-04 | Mach I, Inc. | Polymeric cyclodextrin nitrate esters |
| US7687456B2 (en) | 2005-11-09 | 2010-03-30 | Proteolix, Inc. | Compounds for enzyme inhibition |
| EP2484688B1 (en) | 2006-06-19 | 2016-06-08 | Onyx Therapeutics, Inc. | Peptide epoxyketones for proteasome inhibition |
| MX2010003732A (es) | 2007-10-04 | 2010-08-09 | Onyx Therapeutics Inc | Inhibidores de peptido cetona epoxi de proteasa cristalina y la sintesis de ceto-epoxidos de aminoacido. |
| US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
| PE20120059A1 (es) * | 2008-10-21 | 2012-02-27 | Onyx Therapeutics Inc | Combinaciones farmaceuticas con epoxicetonas peptidicas |
| TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
| US8853147B2 (en) | 2009-11-13 | 2014-10-07 | Onyx Therapeutics, Inc. | Use of peptide epoxyketones for metastasis suppression |
| US9359398B2 (en) | 2010-03-01 | 2016-06-07 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
| WO2011136905A2 (en) | 2010-04-07 | 2011-11-03 | Onyx Therapeutics, Inc. | Crystalline peptide epoxyketone immunoproteasome inhibitor |
| US9751957B2 (en) | 2012-02-15 | 2017-09-05 | Cydex Pharmaceuticals, Inc. | Manufacturing process for cyclodextrin derivatives |
| KR20160033795A (ko) * | 2012-02-28 | 2016-03-28 | 사이덱스 파마슈티칼스, 인크. | 알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법 |
| HUE066956T2 (hu) | 2012-05-08 | 2024-09-28 | Onyx Therapeutics Inc | Peptid proteaszóma inhibitorok formulázására alkalmas ciklodextrin komplexálási eljárások |
| US9309283B2 (en) | 2012-07-09 | 2016-04-12 | Onyx Therapeutics, Inc. | Prodrugs of peptide epoxy ketone protease inhibitors |
| KR102112119B1 (ko) | 2012-10-22 | 2020-05-19 | 사이덱스 파마슈티칼스, 인크. | 알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법 |
| JP6914188B2 (ja) | 2014-08-22 | 2021-08-04 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | 分画アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法 |
| EP3814386A1 (fr) * | 2018-06-29 | 2021-05-05 | Roquette Freres | NOUVELLE HYDROXYPROPYL-ß-CYCLODEXTRINE ET SON PROCÉDÉ DE PRÉPARATION |
| CN112142875A (zh) * | 2019-06-27 | 2020-12-29 | 广东东阳光药业有限公司 | 一种舒更葡糖钠的精制方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3453257A (en) * | 1967-02-13 | 1969-07-01 | Corn Products Co | Cyclodextrin with cationic properties |
| DE2357731A1 (de) * | 1973-11-20 | 1975-05-22 | Merck Patent Gmbh | Verfahren zum austausch von ionischen bestandteilen organischer verbindungen |
| DE2700011A1 (de) * | 1977-01-03 | 1978-07-06 | Hideo Omoto | Hydroxyaethylstaerke, verfahren zu ihrer herstellung und sie enthaltender plasmaersatz |
| JPS6013678B2 (ja) * | 1981-06-08 | 1985-04-09 | 農林水産省食品総合研究所長 | サイクロデキストリンの製造方法 |
| US4870060A (en) * | 1985-03-15 | 1989-09-26 | Janssen Pharmaceutica | Derivatives of γ-cylodextrin |
| JPS62104590A (ja) * | 1985-11-01 | 1987-05-15 | Ensuikou Seito Kk | サイクロデキストリンの製造法 |
| JPS6327440A (ja) † | 1986-07-18 | 1988-02-05 | Sanraku Inc | グルコシル化分岐シクロデキストリン含有組成物 |
| JPS63229109A (ja) * | 1987-03-17 | 1988-09-26 | Asahi Chem Ind Co Ltd | スルホン化ポリフエニレンオキサイド複合半透膜の製造方法 |
| HK1009335A1 (en) * | 1989-04-03 | 1999-05-28 | Janssen Pharmaceutica N.V. | Regioselective substitutions in cyclodextrins |
| KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| JP2905573B2 (ja) * | 1990-06-28 | 1999-06-14 | 日本食品化工株式会社 | ヒドロキシアルキル化シクロデキストリン精製物及びその製造法 |
| US5041227A (en) * | 1990-10-09 | 1991-08-20 | Bend Research, Inc. | Selective aqueous extraction of organics coupled with trapping by membrane separation |
| FR2668163B1 (fr) * | 1990-10-18 | 1993-01-15 | Orsan | Procede de fabrication de beta-cyclodextrine. |
| US5221485A (en) † | 1991-12-03 | 1993-06-22 | Mallinckrodt Medical, Inc. | Purification of X-ray contrast agent, magnetic resonance imaging agent, or radiopharmaceuticals using reverse osmosis |
-
1995
- 1995-02-16 DE DE19505263A patent/DE19505263A1/de not_active Ceased
- 1995-05-31 US US08/454,940 patent/US5831081A/en not_active Expired - Lifetime
-
1996
- 1996-02-14 JP JP8026674A patent/JP2886127B2/ja not_active Expired - Lifetime
- 1996-02-15 EP EP96102245A patent/EP0727440B2/de not_active Expired - Lifetime
- 1996-02-15 DE DE59605527T patent/DE59605527D1/de not_active Expired - Lifetime
Non-Patent Citations (9)
| Title |
|---|
| CA, 1986, 105, 62609 * |
| CA, 1987, 107, 174810 * |
| CA, 1989, 110, 194163 * |
| CA, 1989, 110, 40264 * |
| CA, 1993, 98, 141869 * |
| Derwent 83-08482K/04 (= JP 57202298A) * |
| Derwent 87-054 585/08 (= JP 62011701A) * |
| Derwent 88-073 862/11 (= JP 63027440 A) * |
| Derwent 92-111 446/14 (= JP 04057801 A) * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0727440B1 (de) | 2000-07-05 |
| DE59605527D1 (de) | 2000-08-10 |
| EP0727440B2 (de) | 2003-11-26 |
| EP0727440A2 (de) | 1996-08-21 |
| US5831081A (en) | 1998-11-03 |
| JP2886127B2 (ja) | 1999-04-26 |
| EP0727440A3 (OSRAM) | 1996-08-28 |
| JPH08259605A (ja) | 1996-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0727440B1 (de) | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten | |
| DE69607961T2 (de) | Verfahren zür rückgewinnung wasser-unlöslicher verbindungen aus einer fermentations brühe | |
| AT396930B (de) | Aminoxide | |
| DE3712246C2 (OSRAM) | ||
| DE69411640T2 (de) | Reinigung von wässrigen Reaktions- oder Waschmedium, das Celluloseether enthält | |
| DE4429229A1 (de) | Cyclodextrinderivate mit mindestens einem stickstoffhaltigen Heterozyklus, ihre Herstellung und Verwendung | |
| WO1994028030A1 (de) | Herstellung von polycarboxylaten auf polysaccharid-basis | |
| DE69200322T2 (de) | Verfahren zum konzentrieren und reinigen von organischen verbindungen. | |
| DE102007035322A1 (de) | Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate | |
| DE2504108A1 (de) | Verfahren zur reinigung von pullulan | |
| DE3245591C2 (de) | Verfahren zur fraktionierten Auftrennung von Stoffgemischen mit Membranen | |
| EP0545426B1 (de) | Verfahren zur reinigenden Aufbereitung von bei der Herstellung von Celluloseethern anfallenden Reaktions- und/oder Waschmedien | |
| EP1870390B1 (de) | Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen | |
| EP0657529B2 (de) | Entfärbung von Fermentationslösungen | |
| DE69115849T2 (de) | Verfahren zur Herstellung von 6-(3-Dimethylaminopropionyl)forskolin | |
| DE2640123C3 (de) | Maleinsäuresalz des 2-Phenyl-6-(l-hydroxy-2-tert.-butylaminoäthyl)-4H-pyrido-(3,2-d)-l,3-dioxins, ein Verfahren zur Herstellung desselben sowie ein Verfahren zur Herstellung von 2-Hydroxymethyl-3hydroxy-6-(l -hydroxy-2-tert.-butylaminoäthyD-pyridin | |
| DE4325057C2 (de) | Verfahren zur Herstellung von verzweigten Cyclodextrinen | |
| DE2208631C3 (de) | N-Isobornyloxycarbonylcephalosporin C, Verfahren zu seiner Herstellung und Verwendung zur Herstellung von Cephalosporin C | |
| DE2418088B2 (de) | Verfahren zur abtrennung von cephalosporin c aus seinen waessrigen loesungen in form von urethan-derivaten | |
| DE2121517B2 (de) | Verfahren zur Gewinnung von Ampho tenzin B | |
| WO2002024664A1 (de) | Verfahren zur trennung und hochreinen isolierung von niedermolekularen, strukturell ähnlichen verbindungen, insbesondere von tetrahydropyrimidinderivaten und deren spaltprodukte | |
| DE69611548T2 (de) | Verfahren zur reinigung von 11beta-21-dihydroxy-2'-methyl-5'-betah-pregna-1,4-dieno[17,16-d]-oxazole-3, 20-dione | |
| DE3111276A1 (de) | Celluloseacetylderivate und verfahren zu deren herstellung | |
| JPS60105498A (ja) | 光学活性トリプトフアンの回収方法 | |
| DE2344812A1 (de) | Verfahren zur herstellung von penicillinsulfoxid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8131 | Rejection |